1.
J Am Acad Dermatol
; 83(3): e251-e252, 2020 09.
Article
in English
| MEDLINE | ID: covidwho-592491
Subject(s)
Antibodies, Monoclonal, Humanized/adverse effects , Betacoronavirus/immunology , Coronavirus Infections/epidemiology , Dermatitis, Atopic/drug therapy , Pneumonia, Viral/epidemiology , COVID-19 , Clinical Decision-Making , Coronavirus Infections/immunology , Coronavirus Infections/prevention & control , Coronavirus Infections/virology , Dermatitis, Atopic/immunology , Dermatology/standards , Humans , Interleukin-4 Receptor alpha Subunit/antagonists & inhibitors , Interleukin-4 Receptor alpha Subunit/immunology , Pandemics/prevention & control , Pneumonia, Viral/immunology , Pneumonia, Viral/prevention & control , Pneumonia, Viral/virology , Practice Guidelines as Topic , Randomized Controlled Trials as Topic , Risk Assessment , SARS-CoV-2 , Treatment Outcome
2.
J Eur Acad Dermatol Venereol
; 34(8): e368, 2020 Aug.
Article
in English
| MEDLINE | ID: covidwho-209814